Other subjects

Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan

Carbonaro, T. M., Johnson, M. W., & Griffiths, R. R | Psychopharmacology | 5 June 2020

Psilocybin: from ancient magic to modern medicine

Nichols, D. E. | The Journal of Antibiotics | 12 May 2020

Chronic pain and psychedelics: a review and proposed mechanism of action

Castellanos, J. P., Woolley, C., Bruno, K. A., Zeidan, F., Halberstadt, A., & Furnish, T. | Regional Anesthesia & Pain Medicine | 4 May 2020

The Viability of Microdosing Psychedelics as a Strategy to Enhance Cognition and Well-being – An Early Review

Bornemann, J. | Journal of Psychoactive Drugs | 2 May 2020

Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin

Dahmane, E., Hutson, P. R., & Gobburu, J. V. | Clinical Pharmacology in Drug Development | 06 April 2020

Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications.

O’Callaghan, C., Hubik, D. J., Dwyer, J., Williams, M., & Ross, M. | Journal of Music Therapy | 30 March 2020

Long-term effects of psychedelic drugs: A systematic review

Aday, J. S., Mitzkovitz, C. M., Bloesch, E. K., Davoli, C. C., & Davis, A. K. | Neuroscience & Biobehavioral Reviews | 15 March 2020

The Psychedelic Renaissance and Its Forensic Implications

Holoyda, B. | The journal of the American Academy of Psychiatry and the Law | 09 Mar 2020

Psilocybin Therapeutic Research: The Present and Future Paradigm

Kargbo, R. B. | ACS Medicinal Chemistry Letters | 2 March 2020

Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression

Mertens, L. J., Wall, M. B., Roseman, L., Demetriou, L., Nutt, D. J., & Carhart-Harris, R. L. | Journal of Psychopharmacology | 16 January 2020

A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamine

Palamar, J. J., & Acosta, P. | Clinical and Experimental | 07 January 2020

Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species

Halberstadt, A. L., Chatha, M., Klein, A. K., Wallach, J., & Brandt, S. D. | Neuropharmacology | 7 January 2020

Lysergic acid diethylamide as an analgesic agent in patients with terminal illnesses

Das, S., & Maiti, T. | PAIN MANAGEMENT | 19 December 2019

From Egoism to Ecoism: Psychedelics Increase Nature Relatedness in a State-Mediated and Context-Dependent Manner.

Kettner, H., Gandy, S., Haijen, E. C., & Carhart-Harris, R. L. | International Journal of Environmental Research and Public Health | 16 December 2019

Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe

Miliano, C., Marti, M., Pintori, N., Castelli, M. P., Tirri, M., Arfè, R., & De Luca, M. A. | Frontiers in Pharmacology | 12 December 2019

Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube.

Andersson, M., & Kjellgren, A. | Harm reduction journal | 28 November 2019

The Psilocybin-Telomere Hypothesis: An Empirically Falsifiable Prediction Concerning the Beneficial Neuropsychopharmacological Effects of Psilocybin on Genetic Aging

Germann, C. B. | Medical hypotheses | 24 September 2019

Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects

Smigielski, L., Scheidegger, M., Kometer, M., & Vollenweider, F. X. | NeuroImage | 1 August 2019